Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Carisma Therapeutics Inc.
| Metric | Carisma Therapeutics Inc. CARMHealthcare |
|---|---|
| Quality Score | 56 / 100 |
| Revenue (latest) | $20M |
| Net income (latest) | −$60M |
| Operating margin | −317.2% |
| Net margin | −308.6% |
| Return on equity | 216.7% |
| Return on assets | −198.6% |
| Return on capital (ROCE) | −431.7% |
| Debt / equity | — |
| Revenue growth (YoY) | 31.5% |
| Altman Z″ (distress) | -45.25 |
| Accruals / assets | −1.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.